Company Overview

Update
Headquarters:
Charlotte, NC
IPO:
Went Public on Sep 10, 2004
Stock:
NASDAQ:CHTP
Categories:
Biotechnology

Privaris develops high security biometric applications that authenticate identities before interaction with everyday security systems.

Description

Update

Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), and related conditions and diseases along with its development of prescription products for multiple autoimmune disorders, including rheumatoid arthritis, psoriasis, inflammatory bowel disease and cancer. As of December 31, 2009, it was focused on its drug development resources on two clinical stage development projects: droxidopa for symptomatic NOH and other potential indications, and its portfolio of non-metabolized antifolate compounds for the treatment of rheumatoid arthritis.

Current Team (6)

Update

Board Members and Advisors (9)

Update

Funding Rounds (2) - $24.50M

Update

Investors (1)

Update
  • 97d1c8eb022baa260e004340982638a9

    Venrock

    Venrock is a venture capital firm investing in technology and healthcare companies.

Offices/Locations (1)

Update
  • Office

    3530 Toringdon Way

    Suite 200

    Charlotte, NC 28277

    USA